Insider Transactions Reported by 12 Insiders of AVENUE THERAPEUTICS, INC.

Symbol
ATXI on OTC
Location
Bay Harbor Islands, FL

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

AVENUE THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fortress Biotech, Inc. 10%+ Owner $290,223 02 Jan 2026
Robert L. Davidow 10%+ Owner $170,772 11 Dec 2023
Lucy Lu President, CEO, Director $104,853 17 Dec 2021
Alexandra MacLean Chief Executive Officer, Director $23,800 23 Sep 2024
Joseph Walter Vazzano Chief Financial Officer $23,206 17 Dec 2021
David Jin Interim PFO and COO $9,100 23 Sep 2024
JAY D. KRANZLER Director $1,252 05 Nov 2024
Neil Herskowitz Director $194 02 Dec 2024
InvaGen Pharmaceuticals, Inc. 10%+ Owner 11 Oct 2022
LINDSAY A. ROSENWALD MD Director 23 Sep 2024
Curtis Gale Oltmans Director 23 Sep 2024
Faith L. Charles Director 23 Sep 2024

Recent Insider Transactions by Companies or Individuals for AVENUE THERAPEUTICS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Fortress Biotech, Inc. ATXI COMMON STOCK, PAR VALUE $0.0001 Award 33.8% 111,209 439,733 02 Jan 2026 Direct
Fortress Biotech, Inc. ATXI COMMON STOCK, PAR VALUE $0.0001 Award 11.4% 33,724 328,524 31 Mar 2025 Direct
Neil Herskowitz ATXI COMMON STOCK, PAR VALUE $0.0001 Sale -19.2% $46 $2.00 -23 97 02 Dec 2024 Direct
JAY D. KRANZLER ATXI COMMON STOCK, PAR VALUE $0.0001 Sale -9.84% $137 $2.24 -61 559 05 Nov 2024 Direct
JAY D. KRANZLER ATXI COMMON STOCK, PAR VALUE $0.0001 Purchase 404.1% $1,242 $2.50 497 620 30 Sep 2024 Direct
JAY D. KRANZLER ATXI COMMON STOCK, PAR VALUE $0.0001 Purchase 2.5% $7.2 $2.40 3 123 27 Sep 2024 Direct
LINDSAY A. ROSENWALD MD ATXI Employee stock option (right to buy) Award 30,000 30,000 23 Sep 2024 Direct
Neil Herskowitz ATXI Employee stock option (right to buy) Award 30,000 30,000 23 Sep 2024 Direct
Curtis Gale Oltmans ATXI Employee stock option (right to buy) Award 30,000 30,000 23 Sep 2024 Direct
Alexandra MacLean ATXI COMMON STOCK, PAR VALUE $0.0001 Award 170,000 170,000 23 Sep 2024 Direct
JAY D. KRANZLER ATXI Employee stock option (right to buy) Award 30,000 30,000 23 Sep 2024 Direct
David Jin ATXI COMMON STOCK, PAR VALUE $0.0001 Award 65,000 65,000 23 Sep 2024 Direct
Faith L. Charles ATXI Employee stock option (right to buy) Award 30,000 30,000 23 Sep 2024 Direct
Fortress Biotech, Inc. ATXI COMMON STOCK, PAR VALUE $0.0001 Award 13.2% 413,507 3,547,393 16 Apr 2024 Direct
Fortress Biotech, Inc. ATXI COMMON STOCK, PAR VALUE $0.0001 Award 203.6% 2,101,496 3,133,886 02 Jan 2024 Direct
Robert L. Davidow ATXI Common Stock Sale -27.9% $36,960 $0.1400 -264,000 681,000 11 Dec 2023 Direct
Robert L. Davidow ATXI Common Stock Sale -20% $2,800 $0.1400 -20,000 80,000 11 Dec 2023 By Spouse
Robert L. Davidow ATXI Common Stock Sale -46.6% $17,920 $0.1400 -128,000 147,000 11 Dec 2023 Shared investment authority
Robert L. Davidow ATXI Common Stock Sale -45% $2,700 $0.1500 -18,000 22,000 11 Dec 2023 Joint account with spouse
Robert L. Davidow ATXI Common Stock Sale -45.2% $8,540 $0.1400 -61,000 74,000 11 Dec 2023 Trustee for Juliet Davidow 2001 Trust and Alexander Davidow 2010 Trust
Robert L. Davidow ATXI Common Stock Sale -36.9% $17,640 $0.1400 -126,000 215,800 11 Dec 2023 Shared investment and voting authority
Fortress Biotech, Inc. ATXI Common Stock Purchase 68.2% $301,255 $0.7200 418,410 1,032,390 08 Sep 2023 Direct
LINDSAY A. ROSENWALD MD ATXI Common Stock Purchase 6178.9% $251,046 $0.7200 348,675 354,318 08 Sep 2023 Direct
Faith L. Charles ATXI Employee stock option (right to buy) Award 100,000 100,000 30 Jun 2023 Direct
David Jin ATXI Employee stock option (right to buy) Award 250,000 250,000 30 Jun 2023 Direct
M.D. Lindsay A. Rosenwald ATXI Employee stock option (right to buy) Award 100,000 100,000 30 Jun 2023 Direct
Curtis G. Oltmans ATXI Employee stock option (right to buy) Award 100,000 100,000 30 Jun 2023 Direct
Neil Herskowitz ATXI Employee stock option (right to buy) Award 100,000 100,000 30 Jun 2023 Direct
Jay D. Kranzler ATXI Employee stock option (right to buy) Award 100,000 100,000 30 Jun 2023 Direct
Alexandra MacLean ATXI Employee stock option (right to buy) Award 800,000 800,000 29 Jun 2023 Direct
Fortress Biotech, Inc. ATXI COMMON STOCK, PAR VALUE $0.0001 Award 9.33% 52,419 613,980 31 Mar 2023 Direct
Fortress Biotech, Inc. ATXI COMMON STOCK, PAR VALUE $0.0001 Award 70% 231,316 561,561 03 Jan 2023 Direct
Fortress Biotech, Inc. ATXI COMMON STOCK, PAR VALUE $0.0001 Award 38% 90,909 330,245 31 Dec 2022 Direct
InvaGen Pharmaceuticals, Inc. ATXI Common Stock, par value $0.0001 per share Sale -100% -388,888 0 11 Oct 2022 Direct
Curtis Gale Oltmans ATXI Common Stock Award 49,020 49,020 17 Dec 2021 Direct
Joseph Walter Vazzano ATXI Common Stock Award 154% 100,505 165,757 17 Dec 2021 Direct
M.D. Lucy Lu ATXI Common Stock Award 122% 411,616 748,949 17 Dec 2021 Direct
Neil Herskowitz ATXI Common Stock Award 60.2% 69,020 183,744 17 Dec 2021 Direct
JAY D. KRANZLER ATXI Common Stock Award 106.7% 69,020 133,683 17 Dec 2021 Direct
Joseph Walter Vazzano ATXI Common Stock Sale -9.89% $11,599 $1.62 -7,160 65,252 15 Sep 2021 Direct
Neil Herskowitz ATXI Common Stock Purchase 1.89% $9,975 $3.99 2,500 134,724 06 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.